In this interview we discuss the impact of the Affordable Care Act (ACA) on health disparities, as well as the challenges the law will present for physicians.
In this interview, Dennis Andrulis, PhD, senior research scientist at the Texas Health Institute and associate professor at the University of Texas School of Public Health, discusses the impact the Affordable Care Act (ACA) will have on health disparities, as well as the challenges the law will present for physicians.
Frontline Chemo-Free Regimen Supported in HR+/HER2+ Breast Cancer Therapy
January 1st 2024Combining anastrozole with palbociclib, trastuzumab, and pertuzumab as a frontline therapy for hormone receptor–positive, HER2-positive breast cancer may avoid some of the toxicities associated with chemotherapy, says Amy Tiersten, MD.